Gynaecomastia

Gynaecomastia is a clinical condition characterised by the enlargement of male breast tissue. There is typically no cause found but can be caused by a hormonal imbalance—specifically an increase in oestrogen or a decrease in testosterone—which results in the growth of glandular tissue rather than simple adipose (fat) tissue. It can also be caused by recreational steroid use.

Factors contributing to gynaecomastia may include:

• Hormonal fluctuations: Naturally occurring changes during puberty or ageing.
• Medication side effects: Reactions to certain prescription drugs or substances.
• Genetics and underlying health conditions: Structural changes necessitated by individual physiology.

How is the condition managed?
A formal clinical assessment is required to determine the underlying cause and whether surgical intervention is appropriate. Gynaecomastia surgery (male breast reduction) is a surgical option intended to reduce the volume of fatty and glandular breast tissue and contour skin.

As with all surgical procedures:

• A GP referral is mandatory before an initial consultation can take place.
• Two consultations and a 7-day cooling-off period are required before booking.
• Psychological screening for Body Dysmorphic Disorder (BDD) is a standard part of the assessment process.

Results vary significantly between individuals, and all surgery carries inherent risks.

Gynaecomastia is a frequent clinical finding, affecting an estimated over 50% of the male population at different life stages. It is defined as a benign enlargement of the glandular breast tissue in males.

Common Clinical Presentations:

• Puberty: Approximately half of adolescent males experience transient tissue enlargement due to hormonal shifts. In most cases, this resolves spontaneously within two years.
• Older Age: Prevalence increases in men aged 50–80 as testosterone levels naturally decline relative to oestrogen.
• Medical Triggers: The condition can also be linked to certain medications, underlying health conditions, or lifestyle factors.

While often painless, some individuals experience mastodynia (breast tenderness) or physical discomfort. When gynaecomastia is persistent and does not respond to conservative management, a consultation with Specialist Plastic Surgeon Dr Sophie Ricketts may be appropriate to discuss surgical options.

Gynaecomastia (male breast enlargement) typically occurs during three distinct life stages, primarily driven by fluctuations in the balance between testosterone and oestrogen.

Key Life Stages:

• Infancy (Neonatal): Affects up to 90% of male newborns due to maternal hormones; it typically resolves within weeks.
• Adolescence (Pubertal): Peak onset occurs between ages 12 and 15, affecting approximately half of all teenage boys. In the vast majority of cases, the tissue regresses naturally within two years as hormonal balance is achieved.
• Older Adulthood: Prevalence increases significantly between ages 50 and 80 due to age-related testosterone decline, changes in body composition, or the side effects of certain medications.

Clinical Path Forward
Surgery is generally only considered for “persistent” gynaecomastia—tissue that has remained stable for 12 to 24 months and has not responded to conservative management or the removal of triggering factors. Specialist Plastic Surgeon Dr Sophie Ricketts requires a GP referral to assess the underlying cause before discussing surgical options.

In clinical practice, gynaecomastia can present as either bilateral (affecting both breasts) or unilateral (affecting just one). It is also common for the condition to be asymmetrical, where both sides are involved but to varying degrees of enlargement. Dr Sophie Ricketts, a specialist in treating this condition, often evaluates whether the enlargement is symmetrical and advises on the most suitable management options, including surgery if required.

A suitable candidate for male breast reduction is someone whose condition is medically stable and who meets the health requirements for elective surgery in Australia. Under AHPRA guidelines, surgery is viewed as a clinical intervention for persistent tissue enlargement rather than a lifestyle choice.

Key Clinical Requirements:

• Persistence of Condition: The glandular tissue must have remained stable for at least 12 to 24 months without regressing naturally.
• Health and Lifestyle: Candidates must be in good general health for general anaesthesia. Being a non-smoker is essential, as nicotine significantly increases the risk of wound complications and tissue necrosis.
• Weight Stability: A stable, healthy weight is required to ensure the long-term integrity of the surgical contour.
• Informed Consent: Candidates must have a realistic understanding of surgical outcomes, including the maturation of permanent scars.

Surgical intervention, known as a male breast reduction, is typically considered only after a thorough clinical investigation into the underlying cause of the glandular enlargement. It is generally reserved for cases where the condition is “persistent” and non-surgical pathways have been exhausted.

• Clinical Timing and Criteria
  Tissue Stability: Surgery is generally only considered once the glandular tissue has been stable for at least 12 to 24 months. This is particularly important for pubertal gynaecomastia, as most cases resolve spontaneously once hormonal balance is achieved.
• Failure of Conservative Management: If the enlargement is linked to specific medications, health conditions, or lifestyle factors, these must be addressed first. Surgery is an option only if the tissue remains unchanged after these triggers are removed.
• Physical Symptoms: Surgery may be clinically indicated if the enlargement causes mastodynia (physical pain or tenderness) or significant physical discomfort during daily activities.
• Skin Elasticity: In cases where significant weight loss has occurred, the presence of redundant, inelastic skin may necessitate surgical removal to restore a functional chest contour.

Regulatory Requirements

Before undergoing surgery in Australia, there are several mandatory clinical steps:

• GP Referral: You must obtain a referral from your General Practitioner. This ensures that systemic causes—such as liver, kidney, or endocrine disorders—have been medically investigated.
• Diagnostic Imaging: Specialist Plastic Surgeon Dr Sophie Ricketts often requires a breast ultrasound to distinguish between glandular tissue (gynaecomastia) and adipose tissue (pseudogynaecomastia).
• Cooling-Off Period: A mandatory 7-day cooling-off period is required between your initial consultation and the signing of a consent form to ensure an informed, unpressured decision.

Long-Term Considerations
Surgery provides a long-term solution by physically removing the glandular tissue. However, to maintain the clinical result, patients must maintain a stable weight and avoid medications or substances that could trigger a recurrence of hormonal imbalance.

No. While they may appear similar, gynaecomastia and pseudogynaecomastia are distinct clinical conditions involving different types of tissue. Understanding the difference is critical for determining the appropriate clinical management.

Gynaecomastia (Glandular Growth)
True gynaecomastia is the proliferation of glandular breast tissue in males.

• Cause: It is primarily driven by an imbalance between testosterone and oestrogen.
• Characteristics: The tissue typically feels firm or rubbery and is often located directly behind the nipple-areolar complex. It may be associated with mastodynia (tenderness).
• Management: Glandular tissue is permanent and does not respond to diet or exercise. If conservative monitoring fails, surgical excision is usually required.

Pseudogynaecomastia (Adipose Tissue)
Pseudogynaecomastia is the accumulation of subcutaneous adipose tissue (fat) in the chest area without glandular enlargement.

• Cause: It is generally associated with overall weight gain or individual genetic fat distribution.
• Characteristics: The tissue feels soft and is usually distributed more broadly across the chest wall rather than concentrated behind the nipple.
• Management: This condition may resolve or improve significantly with weight loss and targeted physical activity.

Clinical Assessment
In many cases, a patient may present with a combination of both glandular and fatty tissue. Specialist Plastic Surgeon Dr Sophie Ricketts will perform a physical examination and may request a breast ultrasound to confirm the ratio of gland to fat. This assessment is necessary to determine if liposuction, surgical excision, or a combination of both is required for your anatomical goals.

Recovery after male breast reduction varies between individuals. A compression garment is usually worn after the procedure to support the area and help manage swelling. Bruising, swelling and discomfort are common in the early stages and generally change over the first few weeks.

More strenuous activity is often limited for a period of time, while light activity such as walking may be appropriate earlier, depending on your surgeon’s advice.

Scarring depends on the technique used. When liposuction alone is performed, the incisions are small. If glandular tissue is removed through an incision at the edge of the areola, the scar in that area generally becomes less noticeable over time, although the appearance of scars varies between individuals.

Your surgeon will provide postoperative instructions based on your individual circumstances and the extent of your surgery.